Rajeev Saggar
Vermogen: 11 M $ op 31-05-2026
Vermogen: 11 M $ op 31-05-2026
Rajeev Saggar is currently Chief Medical Officer at Liquidia Corp.
since 2022.
Former positions include Vice President-Clinical Development at Theravance Biopharma Us LLC from 2021 to 2022, and Medical Director-Pulmonary Hypertension & Fibrosis at The Banner-University Medical Center.
Education includes a doctorate from the University of California, Irvine.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0,19% | 13-04-2026 | 173.270 ( 0,19% ) | 11 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| LIQUIDIA CORPORATION | Hoofd Techniek/Wetenschap/O&O | 18-07-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Hoofd Techniek/Wetenschap/O&O | 01-07-2022 |
The Banner-University Medical Center
The Banner-University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Banner-University Medical Center
The Banner-University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Commercial Services |
Liquidia Corp.
Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau